Due to the relatively low expression levels observed in the PC-3 cells in comparison with the other prostate cancer cell lines, the overexpression and knockdown of CMG2 were performed to provide double evidence for its functions in the prostate cancer cells. The gene discussed is ANTXR2; the disease is prostate cancer.